Literature DB >> 29924423

Methods of Enteral Nutrition Administration in Critically Ill Patients: Continuous, Cyclic, Intermittent, and Bolus Feeding.

Satomi Ichimaru1.   

Abstract

There are several methods of enteral nutrition (EN) administration, including continuous, cyclic, intermittent, and bolus techniques, which can be used either alone or in combination. Continuous feeding involves hourly administration of EN over 24 hours assisted by a feeding pump; cyclic feeding involves administration of EN over a time period of <24 hours generally assisted by a feeding pump; intermittent feeding involves administration of EN over 20-60 minutes every 4-6 hours via pump assist or gravity assist; and bolus feeding involves administration of EN over a 4- to 10-minute period using a syringe or gravity drip. In practice, pump-assisted continuous feeding is generally acceptable for critically ill patients to prevent EN-related complications. However, a limited number of studies have been conducted to support this practice. In addition, regarding muscle protein synthesis and gastrointestinal hormone secretion, intermittent or bolus feeding may be more beneficial than continuous EN feeding for critically ill patients. For medically stable patients with feeding tubes terminating in the stomach, bolus feeding is favored with respect to practical factors, such as cost, convenience, and patient mobility. However, few studies have shown whether intermittent or bolus feeding is beneficial in a critical care setting at present. Additional randomized controlled studies comparing intermittent with bolus feeding are required.
© 2018 American Society for Parenteral and Enteral Nutrition.

Entities:  

Keywords:  cost and cost analysis; critical illness; enteral nutrition; nutrition support; patient safety; protein synthesis; respiratory aspiration; tube feeding

Mesh:

Substances:

Year:  2018        PMID: 29924423     DOI: 10.1002/ncp.10105

Source DB:  PubMed          Journal:  Nutr Clin Pract        ISSN: 0884-5336            Impact factor:   3.080


  7 in total

1.  Continuous Feedings Are Not Associated With Lower Rates of Gastroesophageal Reflux When Compared With Bolus Feedings.

Authors:  Lisa B Mahoney; Enju Liu; Rachel Rosen
Journal:  J Pediatr Gastroenterol Nutr       Date:  2019-12       Impact factor: 2.839

Review 2.  [Chronobiological interventions for prevention and treatment of delirium in critically ill patients].

Authors:  Sebastian Schmidt; Laura Hancke; Robert Haussmann; Alawi Luetz
Journal:  Nervenarzt       Date:  2022-07-22       Impact factor: 1.297

Review 3.  When a calorie isn't just a calorie: a revised look at nutrition in critically ill patients with sepsis and acute kidney injury.

Authors:  Mridula Nadamuni; Andrea H Venable; Sarah C Huen
Journal:  Curr Opin Nephrol Hypertens       Date:  2022-06-10       Impact factor: 3.416

4.  From Best Evidence to Best Practice: Enteral Nutrition from Continuous Nasal Feeding in Stroke Patients.

Authors:  Lijuan Sheng; Lihong Yin; Dezhen Peng; Liping Zhao
Journal:  Int J Gen Med       Date:  2020-10-22

Review 5.  Nutrition in Pediatric Intensive Care: A Narrative Review.

Authors:  Milan Kratochvíl; Jozef Klučka; Eva Klabusayová; Tereza Musilová; Václav Vafek; Tamara Skříšovská; Jana Djakow; Pavla Havránková; Denisa Osinová; Petr Štourač
Journal:  Children (Basel)       Date:  2022-07-11

Review 6.  Circadian Disruption in Critical Illness.

Authors:  Aesha M Jobanputra; Matthew T Scharf; Ioannis P Androulakis; Jag Sunderram
Journal:  Front Neurol       Date:  2020-08-11       Impact factor: 4.003

7.  Protein delivery in intermittent and continuous enteral nutrition with a protein-rich formula in critically ill patients-a protocol for the prospective randomized controlled proof-of-concept Protein Bolus Nutrition (Pro BoNo) study.

Authors:  Simona Reinhold; Desirée Yeginsoy; Alexa Hollinger; Atanas Todorov; Lionel Tintignac; Michael Sinnreich; Caroline Kiss; Caroline E Gebhard; Balázs Kovács; Bianca Gysi; Lara Imwinkelried; Martin Siegemund
Journal:  Trials       Date:  2020-08-25       Impact factor: 2.279

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.